{
    "nctId": "NCT04850937",
    "briefTitle": "Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer",
    "officialTitle": "Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Depression",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "depression score",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* (1) Female patients who planned to undergo unilateral modified radical mastectomy in breast surgery; (2)Years of education \u22655 years,American Society of Anesthesiologists \u2160-II grade; (3) All patients undergoing surgery within 1 week after diagnosis of breast cancer, and do not receive preoperative radiotherapy or chemotherapy; (4) All the patients were married and had children, and were mainly cared for by their immediate family members after surgery.\n\nExclusion Criteria:\n\n* (1) Antidepressant treatment was received within the last 2 months; (2) previous personality disorder, intellectual retardation, brain injury or brain disease, combined with schizophrenia, mania and other mental diseases; (3) Preoperative patients with hyperthyroidism or hypothyroidism, severe cardiovascular disease, diabetes, severe blood deficiency, and abnormal heart, lung, liver, and kidney functions; (4) with diseases of the immune system, or use drugs that have obvious effects on the immune system; (5) Pregnancy or lactation;",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}